Molecular Partners Ag
Clinical trials sponsored by Molecular Partners Ag, explained in plain language.
-
New radiation therapy targets tough lung cancers in early trial
Disease control Recruiting nowThis study tests a new drug that delivers radiation directly to cancer cells with a protein called DLL3, found in small cell lung cancer and similar tumors. About 138 adults with advanced cancer that has not responded to standard treatments will receive the drug to check safety, …
Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
New hope for blood cancer patients: experimental drug MP0533 enters human trials
Disease control Recruiting nowThis study tests a new drug called MP0533 in about 249 adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has come back or not responded to treatment. The main goals are to find a safe dose and see if the drug can shrink or control the cancer. Partici…
Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated May 15, 2026 11:56 UTC